The Potential of the Flavonoid Content of L. as an Alternative Analog GLP-1 for Diabetes Type 2 Treatment-Systematic Review.

L. (IBL) has gained significant popularity as a complementary therapy or herbal medicine in the treatment of anti-diabetes. This review seeks to explore the mechanism by which flavonoid compounds derived from IBL exert their anti-diabetic effects through the activation of GLP-1.